カテゴリ： 世界, 医療/バイオ, Market Monitor Global

肝斑治療薬のグローバル市場展望 2023年-2029年：ハイドロキノン、外用レチノイド、外用ステロイド、三種配合クリーム、その他

■ 英語タイトル：Melasma Drug Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14420）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14420
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[肝斑治療薬のグローバル市場展望 2023年-2029年：ハイドロキノン、外用レチノイド、外用ステロイド、三種配合クリーム、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の肝斑治療薬市場規模と予測を収録しています。・世界の肝斑治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の肝斑治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の肝斑治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ハイドロキノン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

肝斑治療薬のグローバル主要企業は、AbbVie, Inc.、 GALDERMA、 Obagi Cosmeceuticals LLC、 Valeant Pharmaceuticals、 Glenmark Pharmaceuticals Ltd.、 Abbott、 MESOESTETIC、 La Pristineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、肝斑治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の肝斑治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の肝斑治療薬市場：タイプ別市場シェア、2022年
・ハイドロキノン、外用レチノイド、外用ステロイド、三種配合クリーム、その他

世界の肝斑治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の肝斑治療薬市場：用途別市場シェア、2022年
・診療所、病院、その他

世界の肝斑治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の肝斑治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における肝斑治療薬のグローバル売上、2018年-2023年
・主要企業における肝斑治療薬のグローバル売上シェア、2022年
・主要企業における肝斑治療薬のグローバル販売量、2018年-2023年
・主要企業における肝斑治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AbbVie, Inc.、 GALDERMA、 Obagi Cosmeceuticals LLC、 Valeant Pharmaceuticals、 Glenmark Pharmaceuticals Ltd.、 Abbott、 MESOESTETIC、 La Pristine

*************************************************************

・調査・分析レポートの概要
肝斑治療薬市場の定義
市場セグメント
世界の肝斑治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の肝斑治療薬市場規模
世界の肝斑治療薬市場規模：2022年 VS 2029年
世界の肝斑治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの肝斑治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の肝斑治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ハイドロキノン、外用レチノイド、外用ステロイド、三種配合クリーム、その他
肝斑治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：診療所、病院、その他
肝斑治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別肝斑治療薬市場規模 2022年と2029年
地域別肝斑治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie, Inc.、 GALDERMA、 Obagi Cosmeceuticals LLC、 Valeant Pharmaceuticals、 Glenmark Pharmaceuticals Ltd.、 Abbott、 MESOESTETIC、 La Pristine
...

This research report provides a comprehensive analysis of the Melasma Drug Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Melasma Drug Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Melasma Drug Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Melasma Drug Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Melasma Drug Treatment market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Melasma Drug Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Melasma Drug Treatment market was valued at US$ 2358 million in 2022 and is projected to reach US$ 4136.9 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Melasma Drug Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Melasma Drug Treatment market.
Market Overview: The report provides a comprehensive overview of the Melasma Drug Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hydroquinone, Topical Retinoid), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Melasma Drug Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Melasma Drug Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Melasma Drug Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Melasma Drug Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Melasma Drug Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Melasma Drug Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Melasma Drug Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Melasma Drug Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Melasma Drug Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hydroquinone
Topical Retinoid
Topical Steroid
Triple Combination Cream
Others
Market segment by Application
Clinic
Hospital
Others
Global Melasma Drug Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AbbVie, Inc.
GALDERMA
Obagi Cosmeceuticals LLC
Valeant Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Abbott
MESOESTETIC
La Pristine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melasma Drug Treatment, market overview.
Chapter 2: Global Melasma Drug Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Melasma Drug Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melasma Drug Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Melasma Drug Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Melasma Drug Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melasma Drug Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melasma Drug Treatment Overall Market Size
2.1 Global Melasma Drug Treatment Market Size: 2022 VS 2029
2.2 Global Melasma Drug Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Melasma Drug Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Melasma Drug Treatment Players in Global Market
3.2 Top Global Melasma Drug Treatment Companies Ranked by Revenue
3.3 Global Melasma Drug Treatment Revenue by Companies
3.4 Global Melasma Drug Treatment Sales by Companies
3.5 Global Melasma Drug Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Melasma Drug Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Melasma Drug Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Melasma Drug Treatment Players in Global Market
3.8.1 List of Global Tier 1 Melasma Drug Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Melasma Drug Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Melasma Drug Treatment Market Size Markets, 2022 & 2029
4.1.2 Hydroquinone
4.1.3 Topical Retinoid
4.1.4 Topical Steroid
4.1.5 Triple Combination Cream
4.1.6 Others
4.2 By Type – Global Melasma Drug Treatment Revenue & Forecasts
4.2.1 By Type – Global Melasma Drug Treatment Revenue, 2018-2023
4.2.2 By Type – Global Melasma Drug Treatment Revenue, 2024-2029
4.2.3 By Type – Global Melasma Drug Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Melasma Drug Treatment Sales & Forecasts
4.3.1 By Type – Global Melasma Drug Treatment Sales, 2018-2023
4.3.2 By Type – Global Melasma Drug Treatment Sales, 2024-2029
4.3.3 By Type – Global Melasma Drug Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Melasma Drug Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Melasma Drug Treatment Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Melasma Drug Treatment Revenue & Forecasts
5.2.1 By Application – Global Melasma Drug Treatment Revenue, 2018-2023
5.2.2 By Application – Global Melasma Drug Treatment Revenue, 2024-2029
5.2.3 By Application – Global Melasma Drug Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Melasma Drug Treatment Sales & Forecasts
5.3.1 By Application – Global Melasma Drug Treatment Sales, 2018-2023
5.3.2 By Application – Global Melasma Drug Treatment Sales, 2024-2029
5.3.3 By Application – Global Melasma Drug Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Melasma Drug Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Melasma Drug Treatment Market Size, 2022 & 2029
6.2 By Region – Global Melasma Drug Treatment Revenue & Forecasts
6.2.1 By Region – Global Melasma Drug Treatment Revenue, 2018-2023
6.2.2 By Region – Global Melasma Drug Treatment Revenue, 2024-2029
6.2.3 By Region – Global Melasma Drug Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Melasma Drug Treatment Sales & Forecasts
6.3.1 By Region – Global Melasma Drug Treatment Sales, 2018-2023
6.3.2 By Region – Global Melasma Drug Treatment Sales, 2024-2029
6.3.3 By Region – Global Melasma Drug Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Melasma Drug Treatment Revenue, 2018-2029
6.4.2 By Country – North America Melasma Drug Treatment Sales, 2018-2029
6.4.3 US Melasma Drug Treatment Market Size, 2018-2029
6.4.4 Canada Melasma Drug Treatment Market Size, 2018-2029
6.4.5 Mexico Melasma Drug Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Melasma Drug Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Melasma Drug Treatment Sales, 2018-2029
6.5.3 Germany Melasma Drug Treatment Market Size, 2018-2029
6.5.4 France Melasma Drug Treatment Market Size, 2018-2029
6.5.5 U.K. Melasma Drug Treatment Market Size, 2018-2029
6.5.6 Italy Melasma Drug Treatment Market Size, 2018-2029
6.5.7 Russia Melasma Drug Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Melasma Drug Treatment Market Size, 2018-2029
6.5.9 Benelux Melasma Drug Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Melasma Drug Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Melasma Drug Treatment Sales, 2018-2029
6.6.3 China Melasma Drug Treatment Market Size, 2018-2029
6.6.4 Japan Melasma Drug Treatment Market Size, 2018-2029
6.6.5 South Korea Melasma Drug Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Melasma Drug Treatment Market Size, 2018-2029
6.6.7 India Melasma Drug Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Melasma Drug Treatment Revenue, 2018-2029
6.7.2 By Country – South America Melasma Drug Treatment Sales, 2018-2029
6.7.3 Brazil Melasma Drug Treatment Market Size, 2018-2029
6.7.4 Argentina Melasma Drug Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Melasma Drug Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Melasma Drug Treatment Sales, 2018-2029
6.8.3 Turkey Melasma Drug Treatment Market Size, 2018-2029
6.8.4 Israel Melasma Drug Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Melasma Drug Treatment Market Size, 2018-2029
6.8.6 UAE Melasma Drug Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie, Inc.
7.1.1 AbbVie, Inc. Company Summary
7.1.2 AbbVie, Inc. Business Overview
7.1.3 AbbVie, Inc. Melasma Drug Treatment Major Product Offerings
7.1.4 AbbVie, Inc. Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie, Inc. Key News & Latest Developments
7.2 GALDERMA
7.2.1 GALDERMA Company Summary
7.2.2 GALDERMA Business Overview
7.2.3 GALDERMA Melasma Drug Treatment Major Product Offerings
7.2.4 GALDERMA Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.2.5 GALDERMA Key News & Latest Developments
7.3 Obagi Cosmeceuticals LLC
7.3.1 Obagi Cosmeceuticals LLC Company Summary
7.3.2 Obagi Cosmeceuticals LLC Business Overview
7.3.3 Obagi Cosmeceuticals LLC Melasma Drug Treatment Major Product Offerings
7.3.4 Obagi Cosmeceuticals LLC Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Obagi Cosmeceuticals LLC Key News & Latest Developments
7.4 Valeant Pharmaceuticals
7.4.1 Valeant Pharmaceuticals Company Summary
7.4.2 Valeant Pharmaceuticals Business Overview
7.4.3 Valeant Pharmaceuticals Melasma Drug Treatment Major Product Offerings
7.4.4 Valeant Pharmaceuticals Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Valeant Pharmaceuticals Key News & Latest Developments
7.5 Glenmark Pharmaceuticals Ltd.
7.5.1 Glenmark Pharmaceuticals Ltd. Company Summary
7.5.2 Glenmark Pharmaceuticals Ltd. Business Overview
7.5.3 Glenmark Pharmaceuticals Ltd. Melasma Drug Treatment Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Ltd. Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Glenmark Pharmaceuticals Ltd. Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Melasma Drug Treatment Major Product Offerings
7.6.4 Abbott Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 MESOESTETIC
7.7.1 MESOESTETIC Company Summary
7.7.2 MESOESTETIC Business Overview
7.7.3 MESOESTETIC Melasma Drug Treatment Major Product Offerings
7.7.4 MESOESTETIC Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.7.5 MESOESTETIC Key News & Latest Developments
7.8 La Pristine
7.8.1 La Pristine Company Summary
7.8.2 La Pristine Business Overview
7.8.3 La Pristine Melasma Drug Treatment Major Product Offerings
7.8.4 La Pristine Melasma Drug Treatment Sales and Revenue in Global (2018-2023)
7.8.5 La Pristine Key News & Latest Developments
8 Global Melasma Drug Treatment Production Capacity, Analysis
8.1 Global Melasma Drug Treatment Production Capacity, 2018-2029
8.2 Melasma Drug Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Melasma Drug Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Melasma Drug Treatment Supply Chain Analysis
10.1 Melasma Drug Treatment Industry Value Chain
10.2 Melasma Drug Treatment Upstream Market
10.3 Melasma Drug Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Melasma Drug Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Melasma Drug Treatment in Global Market
Table 2. Top Melasma Drug Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Melasma Drug Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Melasma Drug Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Melasma Drug Treatment Sales by Companies, (K Units), 2018-2023
Table 6. Global Melasma Drug Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Melasma Drug Treatment Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Melasma Drug Treatment Product Type
Table 9. List of Global Tier 1 Melasma Drug Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melasma Drug Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Melasma Drug Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Melasma Drug Treatment Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Melasma Drug Treatment Sales (K Units), 2018-2023
Table 15. By Type - Global Melasma Drug Treatment Sales (K Units), 2024-2029
Table 16. By Application – Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Melasma Drug Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Melasma Drug Treatment Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Melasma Drug Treatment Sales (K Units), 2018-2023
Table 20. By Application - Global Melasma Drug Treatment Sales (K Units), 2024-2029
Table 21. By Region – Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Melasma Drug Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Melasma Drug Treatment Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Melasma Drug Treatment Sales (K Units), 2018-2023
Table 25. By Region - Global Melasma Drug Treatment Sales (K Units), 2024-2029
Table 26. By Country - North America Melasma Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Melasma Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Melasma Drug Treatment Sales, (K Units), 2018-2023
Table 29. By Country - North America Melasma Drug Treatment Sales, (K Units), 2024-2029
Table 30. By Country - Europe Melasma Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Melasma Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Melasma Drug Treatment Sales, (K Units), 2018-2023
Table 33. By Country - Europe Melasma Drug Treatment Sales, (K Units), 2024-2029
Table 34. By Region - Asia Melasma Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Melasma Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Melasma Drug Treatment Sales, (K Units), 2018-2023
Table 37. By Region - Asia Melasma Drug Treatment Sales, (K Units), 2024-2029
Table 38. By Country - South America Melasma Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Melasma Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Melasma Drug Treatment Sales, (K Units), 2018-2023
Table 41. By Country - South America Melasma Drug Treatment Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Melasma Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Melasma Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Melasma Drug Treatment Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Melasma Drug Treatment Sales, (K Units), 2024-2029
Table 46. AbbVie, Inc. Company Summary
Table 47. AbbVie, Inc. Melasma Drug Treatment Product Offerings
Table 48. AbbVie, Inc. Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AbbVie, Inc. Key News & Latest Developments
Table 50. GALDERMA Company Summary
Table 51. GALDERMA Melasma Drug Treatment Product Offerings
Table 52. GALDERMA Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GALDERMA Key News & Latest Developments
Table 54. Obagi Cosmeceuticals LLC Company Summary
Table 55. Obagi Cosmeceuticals LLC Melasma Drug Treatment Product Offerings
Table 56. Obagi Cosmeceuticals LLC Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Obagi Cosmeceuticals LLC Key News & Latest Developments
Table 58. Valeant Pharmaceuticals Company Summary
Table 59. Valeant Pharmaceuticals Melasma Drug Treatment Product Offerings
Table 60. Valeant Pharmaceuticals Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Valeant Pharmaceuticals Key News & Latest Developments
Table 62. Glenmark Pharmaceuticals Ltd. Company Summary
Table 63. Glenmark Pharmaceuticals Ltd. Melasma Drug Treatment Product Offerings
Table 64. Glenmark Pharmaceuticals Ltd. Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Glenmark Pharmaceuticals Ltd. Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Melasma Drug Treatment Product Offerings
Table 68. Abbott Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. MESOESTETIC Company Summary
Table 71. MESOESTETIC Melasma Drug Treatment Product Offerings
Table 72. MESOESTETIC Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. MESOESTETIC Key News & Latest Developments
Table 74. La Pristine Company Summary
Table 75. La Pristine Melasma Drug Treatment Product Offerings
Table 76. La Pristine Melasma Drug Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. La Pristine Key News & Latest Developments
Table 78. Melasma Drug Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Melasma Drug Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Melasma Drug Treatment Production by Region, 2018-2023 (K Units)
Table 81. Global Melasma Drug Treatment Production by Region, 2024-2029 (K Units)
Table 82. Melasma Drug Treatment Market Opportunities & Trends in Global Market
Table 83. Melasma Drug Treatment Market Drivers in Global Market
Table 84. Melasma Drug Treatment Market Restraints in Global Market
Table 85. Melasma Drug Treatment Raw Materials
Table 86. Melasma Drug Treatment Raw Materials Suppliers in Global Market
Table 87. Typical Melasma Drug Treatment Downstream
Table 88. Melasma Drug Treatment Downstream Clients in Global Market
Table 89. Melasma Drug Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Melasma Drug Treatment Segment by Type in 2022
Figure 2. Melasma Drug Treatment Segment by Application in 2022
Figure 3. Global Melasma Drug Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Melasma Drug Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Melasma Drug Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. Melasma Drug Treatment Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Melasma Drug Treatment Revenue in 2022
Figure 9. By Type - Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 11. By Type - Global Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 12. By Type - Global Melasma Drug Treatment Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 15. By Application - Global Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 16. By Application - Global Melasma Drug Treatment Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Melasma Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Melasma Drug Treatment Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 20. By Region - Global Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 21. By Country - North America Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 22. By Country - North America Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 23. US Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 28. Germany Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. France Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 37. China Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. India Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 43. By Country - South America Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 44. Brazil Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Melasma Drug Treatment Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Melasma Drug Treatment Sales Market Share, 2018-2029
Figure 48. Turkey Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Melasma Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 52. Global Melasma Drug Treatment Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Melasma Drug Treatment by Region, 2022 VS 2029
Figure 54. Melasma Drug Treatment Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 重合禁止剤のグローバル市場展望 2023年-2029年：ハイドロキノン、キニーネ、芳香族ニトロ化合物、アミン、その他
  • カテコール＆ハイドロキノンのグローバル市場展望 2023年-2029年：カテコール、ハイドロキノン
  • 過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他
  • トラマドール医薬品のグローバル市場展望 2023年-2029年：錠剤、カプセル、液体、懸濁液、その他
  • 植物薬のグローバル市場展望 2023年-2029年：医療用医薬品、OTC
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14420 )"肝斑治療薬のグローバル市場展望 2023年-2029年：ハイドロキノン、外用レチノイド、外用ステロイド、三種配合クリーム、その他" (英文：Melasma Drug Treatment Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。